Biochemical Engineering

UCB Expands Innovation Footprint with New Gene Therapy Facility

UCB Expands Innovation Footprint with New Gene Therapy Facility

10th March 2022

UCB announced on March 8, 2022 that it will build a new innovative facility, focused on gene therapy process development and clinical manufacturing, in Wallonia, Belgium. The 17,0000-sq.-ft. facility is expected to be operational in 2024 and will provide end-to-end process and analytical development, clinical manufacturing, quality control, scalability, and speed to UCB’s gene therapy research projects. Source: Biopharm International 10/3/22


Back to group news